Antibody-mediated gastrointestinal dysmotility in scleroderma

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1988 • 19,632 citations

Revised Criteria for the Classification of Rheumatoid Arthritis

1990 • 7,730 citations

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1980 • 4,703 citations

The isolation of IgG from mammalian sera with the aid of caprylic acid

1969 • 874 citations

Types of neurons in the enteric nervous system

2000 • 803 citations

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor

1999 • 800 citations

Assessment of the European classification criteria for Sjogren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren's Syndrome.

1996 • 468 citations

Gastrointestinal motility disorders in scleroderma

1994 • 374 citations

Physiological Features of Visceral Smooth Muscle Cells, With Special Reference to Receptors and Ion Channels

1998 • 249 citations

Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome

2000 • 236 citations

Anti-β1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: Mapping of epitopes in the first and second extracellular loops

1995 • 195 citations

The Pathogenesis of Esophageal Dysfunction in Scleroderma and Raynaud's Disease

1972 • 191 citations

Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren’s syndrome

1996 • 188 citations

Scleroderma of the Esophagus

1963 • 175 citations

Arrhythmogenicity of IgG and Anti-52-kD SSA/Ro Affinity-Purified Antibodies From Mothers of Children With Congenital Heart Block

1997 • 161 citations

Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome.

1998 • 152 citations

GASTROINTESTINAL MANIFESTATIONS OF SCLERODERMA

1998 • 149 citations

Human autoantibodies specific for the α _1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons

1998 • 113 citations

The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo

2002 • 109 citations

Interdigestive motor activity in patients with systemic sclerosis.

1982 • 102 citations

Antimyenteric neuronal antibodies in scleroderma.

1994 • 99 citations

The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo

2002 • 99 citations

Abnormal Colonic Motility in Progressive Systemic Sclerosis

1981 • 89 citations

Interdiestive Motor Activity in Patients with Systemic Sclerosis

1982 • 82 citations

Functional implications of circulating muscarinic cholinergic receptor autoantibodies in chagasic patients with achalasia

1999 • 77 citations

Role of Neurotransmitter Autoantibodies in the Pathogenesis of Chagasic Peripheral Dysautonomia

2000 • 72 citations

Myenteric neuronal antibodies in scleroderma: Passive transfer evokes alterations in intestinal myoelectric activity in a rat model

1999 • 57 citations

Autoantibodies against M2 muscarinic receptors in patients with cardiomyopathy display non-desensitized agonist-like effects

1999 • 49 citations

Autoantibodies to Nuclear Antigens Correlation Between Cytotoxicity and DNA-Hydrolyzing Activity

2000 • 41 citations

Sjögren autoantibodies modify neonatal cardiac function via M1 muscarinic acetylcholine receptor activation

1999 • 37 citations

Autoantibodies interacting with purified native thyrotropin receptor

1999 • 34 citations

Functional evaluation of inhibition of autonomic transmitter release by autoantibody from lambert eaton myasthenic syndrome

1998 • 18 citations